ACADIA Pharmaceuticals (NASDAQ:ACAD) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ACADIA Pharmaceuticals missed estimated earnings by 16.67%, reporting an EPS of $-0.7 versus an estimate of $-0.6.
Revenue was up $8.91 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 1.34% drop in the share price the next day.
Here's a look at ACADIA Pharmaceuticals's past performance:
To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
